Texas uni loses bid to shield cancer vaccine patents from IPRs

The University of Texas (UT) has failed to persuade the US Court of Appeals for the Federal Circuit to review a ruling that prevented it from using sovereign immunity to protect its cancer vaccine patents from inter partes reviews (IPRs).

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

Texas Uni’s sovereign immunity fail went as expected

4 March 2021 The result of the sovereign immunity bid mirrored previous cases but we did learn something about the opinions of Justices on the issue, says Gary Frischling of Milbank.

Americas

Texas uni wants Supreme Court to settle state sovereignty rules

12 March 2020 The University of Texas has asked the Supreme Court to rule that state-owned institutions should escape the normal rules determining the appropriate venue for filing patent lawsuits.

Americas

Texas universities sue J&J subsidiary over biodegradable fibres

17 November 2017 A group of 14 educational institutions in Texas and biotech company TissueGen have sued a subsidiary of Johnson & Johnson for infringing two patents covering biodegradable fibres.

More on this story

Americas

Texas Uni’s sovereign immunity fail went as expected

4 March 2021 The result of the sovereign immunity bid mirrored previous cases but we did learn something about the opinions of Justices on the issue, says Gary Frischling of Milbank.

Americas

Texas uni wants Supreme Court to settle state sovereignty rules

12 March 2020 The University of Texas has asked the Supreme Court to rule that state-owned institutions should escape the normal rules determining the appropriate venue for filing patent lawsuits.

Americas

Texas universities sue J&J subsidiary over biodegradable fibres

17 November 2017 A group of 14 educational institutions in Texas and biotech company TissueGen have sued a subsidiary of Johnson & Johnson for infringing two patents covering biodegradable fibres.

More on this story

Americas

Texas Uni’s sovereign immunity fail went as expected

4 March 2021 The result of the sovereign immunity bid mirrored previous cases but we did learn something about the opinions of Justices on the issue, says Gary Frischling of Milbank.

Americas

Texas uni wants Supreme Court to settle state sovereignty rules

12 March 2020 The University of Texas has asked the Supreme Court to rule that state-owned institutions should escape the normal rules determining the appropriate venue for filing patent lawsuits.

Americas

Texas universities sue J&J subsidiary over biodegradable fibres

17 November 2017 A group of 14 educational institutions in Texas and biotech company TissueGen have sued a subsidiary of Johnson & Johnson for infringing two patents covering biodegradable fibres.

More features

Fed Circ orders Teva to delist five patents from Orange Book

Sarepta wins $115M in patent dispute over muscular dystrophy drug

Novartis shields eye-drop patent at European Patent Office

CREATES Act unfairly tips the scales to generics

LSPN launches its first-ever US awards to celebrate life sciences leaders

Pharma giants seek closure on COVID-19 vaccine rows

How Inhibrx defended a $450m damages suit

Foley & Lardner adds litigation and transaction expert in New York

Texas uni loses bid to shield cancer vaccine patents from IPRs

More on this story

Editor's picks

Editor's picks

More on this story

More on this story

More features